Literature DB >> 23177319

Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization.

Shaun Spence1, Amy Fitzsimons, Caroline R Boyd, Julia Kessler, Denise Fitzgerald, Joanne Elliott, Joan Ní Gabhann, Siobhan Smith, Antonio Sica, Emily Hams, Sean P Saunders, Caroline A Jefferies, Padraic G Fallon, Danny F McAuley, Adrien Kissenpfennig, James A Johnston.   

Abstract

Suppressors of cytokine signaling (SOCS) are important regulators of lipopolysaccharide (LPS) and cytokine responses but their role in macrophage polarization is unknown. We have shown here that myeloid-restricted Socs3 deletion (Socs3(Lyz2cre)) resulted in resistance to LPS-induced endotoxic shock, whereas Socs2(-/-) mice were highly susceptible. We observed striking bias toward M2-like macrophages in Socs3(Lyz2cre) mice, whereas the M1-like population was enriched in Socs2(-/-) mice. Adoptive transfer experiments showed that responses to endotoxic shock and polymicrobial sepsis were transferable and macrophage dependent. Critically, this dichotomous response was associated with enhanced regulatory T (Treg) cell recruitment by Socs3(Lyz2cre) cells, whereas Treg cell recruitment was absent in the presence of Socs2(-/-) macrophages. In addition, altered polarization coincided with enhanced interferon-gamma (IFN-γ)-induced signal transducer and activator of transcription-1 (STAT1) activation in Socs2(-/-) macrophages and enhanced interleukin-4 (IL-4) plus IL-13-induced STAT6 phosphorylation in Socs3(Lyz2cre) macrophages. SOCS, therefore, are essential controllers of macrophage polarization, regulating inflammatory responses.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23177319     DOI: 10.1016/j.immuni.2012.09.013

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  43 in total

Review 1.  Molecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic target.

Authors:  Elizabeth A Grimm; Andrew G Sikora; Suhendan Ekmekcioglu
Journal:  Clin Cancer Res       Date:  2013-07-18       Impact factor: 12.531

2.  Therapeutically reeducating macrophages to treat GBM.

Authors:  Christopher Garris; Mikael J Pittet
Journal:  Nat Med       Date:  2013-10       Impact factor: 53.440

3.  Local Injection of Lenti-BDNF at the Lesion Site Promotes M2 Macrophage Polarization and Inhibits Inflammatory Response After Spinal Cord Injury in Mice.

Authors:  Xin-Chao Ji; Yuan-Yuan Dang; Hong-Yan Gao; Zhao-Tao Wang; Mou Gao; Yi Yang; Hong-Tian Zhang; Ru-Xiang Xu
Journal:  Cell Mol Neurobiol       Date:  2015-04-04       Impact factor: 5.046

Review 4.  Diverse macrophage populations mediate acute lung inflammation and resolution.

Authors:  Neil R Aggarwal; Landon S King; Franco R D'Alessio
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-02-07       Impact factor: 5.464

5.  Mannose receptor modulates macrophage polarization and allergic inflammation through miR-511-3p.

Authors:  Yufeng Zhou; Danh C Do; Faoud T Ishmael; Mario Leonardo Squadrito; Ho Man Tang; Ho Lam Tang; Man-Hsun Hsu; Lipeng Qiu; Changjun Li; Yongqing Zhang; Kevin G Becker; Mei Wan; Shau-Ku Huang; Peisong Gao
Journal:  J Allergy Clin Immunol       Date:  2017-06-17       Impact factor: 10.793

Review 6.  Immunology Comes Full Circle in Melanoma While Specific Immunity Is Unleashed to Eliminate Metastatic Disease, Inflammatory Products of Innate Immunity Promote Resistance.

Authors:  Elizabeth A Grimm
Journal:  Crit Rev Oncog       Date:  2016

Review 7.  The therapeutic potential of interleukin-10 in neuroimmune diseases.

Authors:  A J Kwilasz; P M Grace; P Serbedzija; S F Maier; L R Watkins
Journal:  Neuropharmacology       Date:  2014-11-04       Impact factor: 5.250

8.  Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival.

Authors:  Maryelise Cieslewicz; Jingjing Tang; Jonathan L Yu; Hua Cao; Maja Zavaljevski; Koka Motoyama; Andre Lieber; Elaine W Raines; Suzie H Pun
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-17       Impact factor: 11.205

Review 9.  Dendritic cells as therapeutic targets in neuroinflammation.

Authors:  Felix Luessi; Frauke Zipp; Esther Witsch
Journal:  Cell Mol Life Sci       Date:  2016-03-12       Impact factor: 9.261

10.  Polycomb-mediated loss of microRNA let-7c determines inflammatory macrophage polarization via PAK1-dependent NF-κB pathway.

Authors:  W Zhang; H Liu; W Liu; Y Liu; J Xu
Journal:  Cell Death Differ       Date:  2014-09-12       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.